Investing.com investing.com 03 Jan, 2021 07:45 am

India approves AstraZeneca and local COVID vaccines, rollout in weeks By Reuters

India approves AstraZeneca and local COVID vaccines, rollout in weeks By Reuters
India approves AstraZeneca and local COVID vaccines, rollout in weeks

World 1 hour ago (Jan 03, 2021 01:45AM ET) By Aftab Ahmed and Nigam Prusty NEW DELHI (Reuters) - India's drugs regulator on Sunday gave final approval for the emergency-use of two coronavirus vaccines, one developed by AstraZeneca (NASDAQ: AZN ) and Oxford University and the other by local company Bharat Biotech.The world's second most populous country is now expected to start a massive immunisation programme within weeks, with the AstraZeneca/Oxford shot taking the lead and Bharat Biotech's COVAXIN administered under stricter conditions given no efficacy data has been release for it.42%, while Bharat Biotech's COVAXIN was "safe and provides a robust immune response", Drugs Controller General of India V.The British-developed AstraZeneca/Oxford shot is being made locally by the Serum Institute of India (SII) and will be branded COVISHIELD, while Bharat Biotech has teamed up with the government-run Indian Council of Medical Research.

"Vaccines of M/s Serum and M/s Bharat Biotech are being approved for restricted use in emergency situations," Somani read out from a written statement at a press conference.Somani explained that the Bharat Biotech vaccine had been approved "in public interest as an abundant precaution, in clinical trial mode, to have more options for vaccinations, especially in case of infection by mutant strains".

Read full story at investing.com